Dynavax Clears Heplisav-B Hurdle With CDC Recommendation

By: via Benzinga
What Happened Dynavax Technologies Corporation (NASDAQ: DVAX) traded up 3.7 percent Wednesday after management announced the Centers ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.